He Yu - Anpac Bio CoFounder Officer
| ANPCDelisted Stock | USD 4.37 0.20 4.38% |
Insider
He Yu is CoFounder Officer of Anpac Bio Medical
| Age | 65 |
| Phone | 86 57 8205 1666 |
| Web | https://www.anpacbio.com |
Anpac Bio Management Efficiency
The company has return on total asset (ROA) of (0.5264) % which means that it has lost $0.5264 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.4312) %, meaning that it created substantial loss on money invested by shareholders. Anpac Bio's management efficiency ratios could be used to measure how well Anpac Bio manages its routine affairs as well as how well it operates its assets and liabilities.Anpac Bio Medical currently holds 19.81 M in liabilities with Debt to Equity (D/E) ratio of 1.44, which is about average as compared to similar companies. Anpac Bio Medical has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Anpac Bio's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Alley | AN2 Therapeutics | N/A | |
| Scott Anderson | Anebulo Pharmaceuticals | N/A | |
| Thomas Shenk | Pmv Pharmaceuticals | 77 | |
| David Lovejoy | Protagenic Therapeutics | N/A | |
| Rex CFA | Anebulo Pharmaceuticals | 64 | |
| Leeds Chow | ABVC Biopharma | 35 | |
| MD FACP | AN2 Therapeutics | 76 | |
| Eric Devroe | Acrivon Therapeutics, Common | 45 | |
| George Eldridge | Aerovate Therapeutics | 61 | |
| Daniel Hicklin | Werewolf Therapeutics | 60 | |
| Donna Dea | Aerovate Therapeutics | N/A | |
| Crystal Mercado | Acrivon Therapeutics, Common | N/A | |
| Lance Laing | Celcuity LLC | 62 | |
| Andrew Slee | Protagenic Therapeutics | 74 | |
| Mythili MD | Marker Therapeutics | 46 | |
| Timothy Pigot | Aerovate Therapeutics | 53 | |
| Josh Eizen | AN2 Therapeutics | N/A | |
| MBA MR | Aerovate Therapeutics | 62 | |
| Michael Carruthers | Edgewise Therapeutics | 66 | |
| Kristina Zambouras | C4 Therapeutics | N/A | |
| Dabt Ph | Celcuity LLC | 67 | |
Management Performance
| Return On Equity | -2.43 | |||
| Return On Asset | -0.53 |
Anpac Bio Medical Leadership Team
Elected by the shareholders, the Anpac Bio's board of directors comprises two types of representatives: Anpac Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anpac. The board's role is to monitor Anpac Bio's management team and ensure that shareholders' interests are well served. Anpac Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anpac Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sunil Pandit, US Officer | ||
| Xiaoyu Li, CFO Director | ||
| Weidong Dai, China Pres | ||
| Haohan Xu, CoCEO CoChairperson | ||
| He Yu, CoFounder Officer | ||
| Chris Yu, CoCEO CoFounder |
Anpac Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Anpac Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.43 | |||
| Return On Asset | -0.53 | |||
| Operating Margin | (8.71) % | |||
| Current Valuation | 9.28 M | |||
| Shares Outstanding | 6.27 M | |||
| Shares Owned By Insiders | 2.15 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Number Of Shares Shorted | 44.48 K | |||
| Price To Book | 5.67 X | |||
| Price To Sales | 0.41 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |